Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery

Daniel J. Lee, Brett Maseyesva, William Westra, Donlin Long, John K. Niparko, Joseph Califano

Research output: Contribution to journalArticle

Abstract

Hypothesis: Genetic and immunohistochemical studies may provide insight into the mechanisms of vestibular schwannoma (VS) recurrence following radiation therapy. Background: Stereotactic radiation therapy is an increasingly common alternative to microsurgical resection for the primary management of sporadic VS. The molecular mechanisms associated with recurrent vestibular schwannoma (VS) following radiation therapy are not known. Methods: Primary or irradiated VS tumors were fresh-frozen at the time of surgical resection and microdissected to undergo DNA extraction. Lymphocytic control DNA was isolated from blood obtained by venipuncture. Paired normal and tumor DNA specimens were analyzed for allelic loss by PCR amplification of polymorphic dinucleotide repeat sequences. Immunohistochemical studies were performed on paraffin-embedded, irradiated surgical specimens. Results: Using 16 polymorphic microsatellite markers, 20 of 26 non-irradiated VS demonstrated loss of heterozygosity (LOH) in at least one locus of chromosome 22q. In contrast, none of the four irradiated recurrent VS demonstrated LOH on chromosome 22q (p = 0.008). No allelic loss was seen in either the primary or irradiated VS utilizing markers mapping to chromosome 10. Deletions on chromosome 10 are seen in both benign and higher-grade meningiomas and intracranial malignancies associated with radiotherapy. Immunohistochemical studies were performed to detect the protein product of the NF2 gene, merlin, in the four irradiated VS. NF2 staining was not observed. Conclusion: This study represents the first microsatellite and immunohistochemical analysis of recurrent VS following radiation therapy. Our preliminary observations suggest an alternative mechanism of NF2 inactivation that may correlate with radioresistance in VS.

Original languageEnglish (US)
Pages (from-to)213-219
Number of pages7
JournalOtology and Neurotology
Volume27
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Acoustic Neuroma
Radiosurgery
Microsatellite Repeats
Loss of Heterozygosity
Radiotherapy
Chromosomes, Human, Pair 10
DNA
Chromosomes
Neurofibromin 2
Dinucleotide Repeats
Background Radiation
Neoplasms
Phlebotomy
Meningioma
Paraffin
Staining and Labeling
Recurrence
Polymerase Chain Reaction

Keywords

  • Loss of heterozygosity
  • Microsatellite
  • Stereotactic radiation
  • Vestibular schwannoma

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Neuroscience(all)

Cite this

Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery. / Lee, Daniel J.; Maseyesva, Brett; Westra, William; Long, Donlin; Niparko, John K.; Califano, Joseph.

In: Otology and Neurotology, Vol. 27, No. 2, 02.2006, p. 213-219.

Research output: Contribution to journalArticle

Lee, Daniel J. ; Maseyesva, Brett ; Westra, William ; Long, Donlin ; Niparko, John K. ; Califano, Joseph. / Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery. In: Otology and Neurotology. 2006 ; Vol. 27, No. 2. pp. 213-219.
@article{4db09176f6f3483daa6e3baac268d79c,
title = "Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery",
abstract = "Hypothesis: Genetic and immunohistochemical studies may provide insight into the mechanisms of vestibular schwannoma (VS) recurrence following radiation therapy. Background: Stereotactic radiation therapy is an increasingly common alternative to microsurgical resection for the primary management of sporadic VS. The molecular mechanisms associated with recurrent vestibular schwannoma (VS) following radiation therapy are not known. Methods: Primary or irradiated VS tumors were fresh-frozen at the time of surgical resection and microdissected to undergo DNA extraction. Lymphocytic control DNA was isolated from blood obtained by venipuncture. Paired normal and tumor DNA specimens were analyzed for allelic loss by PCR amplification of polymorphic dinucleotide repeat sequences. Immunohistochemical studies were performed on paraffin-embedded, irradiated surgical specimens. Results: Using 16 polymorphic microsatellite markers, 20 of 26 non-irradiated VS demonstrated loss of heterozygosity (LOH) in at least one locus of chromosome 22q. In contrast, none of the four irradiated recurrent VS demonstrated LOH on chromosome 22q (p = 0.008). No allelic loss was seen in either the primary or irradiated VS utilizing markers mapping to chromosome 10. Deletions on chromosome 10 are seen in both benign and higher-grade meningiomas and intracranial malignancies associated with radiotherapy. Immunohistochemical studies were performed to detect the protein product of the NF2 gene, merlin, in the four irradiated VS. NF2 staining was not observed. Conclusion: This study represents the first microsatellite and immunohistochemical analysis of recurrent VS following radiation therapy. Our preliminary observations suggest an alternative mechanism of NF2 inactivation that may correlate with radioresistance in VS.",
keywords = "Loss of heterozygosity, Microsatellite, Stereotactic radiation, Vestibular schwannoma",
author = "Lee, {Daniel J.} and Brett Maseyesva and William Westra and Donlin Long and Niparko, {John K.} and Joseph Califano",
year = "2006",
month = "2",
doi = "10.1097/01.mao.0000199753.44191.73",
language = "English (US)",
volume = "27",
pages = "213--219",
journal = "Otology and Neurotology",
issn = "1531-7129",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery

AU - Lee, Daniel J.

AU - Maseyesva, Brett

AU - Westra, William

AU - Long, Donlin

AU - Niparko, John K.

AU - Califano, Joseph

PY - 2006/2

Y1 - 2006/2

N2 - Hypothesis: Genetic and immunohistochemical studies may provide insight into the mechanisms of vestibular schwannoma (VS) recurrence following radiation therapy. Background: Stereotactic radiation therapy is an increasingly common alternative to microsurgical resection for the primary management of sporadic VS. The molecular mechanisms associated with recurrent vestibular schwannoma (VS) following radiation therapy are not known. Methods: Primary or irradiated VS tumors were fresh-frozen at the time of surgical resection and microdissected to undergo DNA extraction. Lymphocytic control DNA was isolated from blood obtained by venipuncture. Paired normal and tumor DNA specimens were analyzed for allelic loss by PCR amplification of polymorphic dinucleotide repeat sequences. Immunohistochemical studies were performed on paraffin-embedded, irradiated surgical specimens. Results: Using 16 polymorphic microsatellite markers, 20 of 26 non-irradiated VS demonstrated loss of heterozygosity (LOH) in at least one locus of chromosome 22q. In contrast, none of the four irradiated recurrent VS demonstrated LOH on chromosome 22q (p = 0.008). No allelic loss was seen in either the primary or irradiated VS utilizing markers mapping to chromosome 10. Deletions on chromosome 10 are seen in both benign and higher-grade meningiomas and intracranial malignancies associated with radiotherapy. Immunohistochemical studies were performed to detect the protein product of the NF2 gene, merlin, in the four irradiated VS. NF2 staining was not observed. Conclusion: This study represents the first microsatellite and immunohistochemical analysis of recurrent VS following radiation therapy. Our preliminary observations suggest an alternative mechanism of NF2 inactivation that may correlate with radioresistance in VS.

AB - Hypothesis: Genetic and immunohistochemical studies may provide insight into the mechanisms of vestibular schwannoma (VS) recurrence following radiation therapy. Background: Stereotactic radiation therapy is an increasingly common alternative to microsurgical resection for the primary management of sporadic VS. The molecular mechanisms associated with recurrent vestibular schwannoma (VS) following radiation therapy are not known. Methods: Primary or irradiated VS tumors were fresh-frozen at the time of surgical resection and microdissected to undergo DNA extraction. Lymphocytic control DNA was isolated from blood obtained by venipuncture. Paired normal and tumor DNA specimens were analyzed for allelic loss by PCR amplification of polymorphic dinucleotide repeat sequences. Immunohistochemical studies were performed on paraffin-embedded, irradiated surgical specimens. Results: Using 16 polymorphic microsatellite markers, 20 of 26 non-irradiated VS demonstrated loss of heterozygosity (LOH) in at least one locus of chromosome 22q. In contrast, none of the four irradiated recurrent VS demonstrated LOH on chromosome 22q (p = 0.008). No allelic loss was seen in either the primary or irradiated VS utilizing markers mapping to chromosome 10. Deletions on chromosome 10 are seen in both benign and higher-grade meningiomas and intracranial malignancies associated with radiotherapy. Immunohistochemical studies were performed to detect the protein product of the NF2 gene, merlin, in the four irradiated VS. NF2 staining was not observed. Conclusion: This study represents the first microsatellite and immunohistochemical analysis of recurrent VS following radiation therapy. Our preliminary observations suggest an alternative mechanism of NF2 inactivation that may correlate with radioresistance in VS.

KW - Loss of heterozygosity

KW - Microsatellite

KW - Stereotactic radiation

KW - Vestibular schwannoma

UR - http://www.scopus.com/inward/record.url?scp=33645046892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645046892&partnerID=8YFLogxK

U2 - 10.1097/01.mao.0000199753.44191.73

DO - 10.1097/01.mao.0000199753.44191.73

M3 - Article

C2 - 16436992

AN - SCOPUS:33645046892

VL - 27

SP - 213

EP - 219

JO - Otology and Neurotology

JF - Otology and Neurotology

SN - 1531-7129

IS - 2

ER -